Device / Technology News

RSS

Clarient adopts QIAGEN’s therascreen KRAS test to diagnose colorectal cancer

QIAGEN N.V. today announced that Clarient - a GE Healthcare Company and leading provider of cancer laboratory testing services in the United States - has adopted the use of the therascreen KRAS RGQ PCR Kit (therascreen KRAS test) as a companion diagnostic to guide the use of Erbitux (cetuximab) as a treatment in patients with metastatic colorectal cancer.

From QIAGEN Manchester Limited 30 Jan 2013

Wake Forest expands football helmet research to reduce sports concussion risks

Wake Forest University School of Biomedical Engineering and Sciences is expanding its ground-breaking research of testing football helmets to reduce the number of concussions to now include hockey, baseball, softball, and lacrosse.

30 Jan 2013

New interactive wobbleboard can allow clinicians to better measure improvements in patients' balance

A physiotherapy lecturer at Bournemouth University (BU) has created a new interactive wobbleboard that will allow clinicians to better measure improvements in patients' balance.

30 Jan 2013

Researchers determine precise configuration of humulones

Researchers employing a century-old observational technique have determined the precise configuration of humulones, substances derived from hops that give beer its distinctive flavor.

30 Jan 2013

UCLA's Laboratory of Neuro Imaging to use expertise to piece together brain's puzzle

UCLA's Laboratory of Neuro Imaging (LONI) has entered into a partnership with academic centers from Europe and around the world in a massive, unprecedented effort to understand the human brain.

30 Jan 2013

Noninvasive, drugless therapy may help mitigate symptoms associated with neurological conditions

With the infusion of an additional $1 million of financial support from The Susanne Marcus Collins Foundation, Inc., Atlanta, GA, Wake Forest Baptist Medical Center researchers are expanding their studies using a noninvasive, drugless therapy that may help to mitigate symptoms associated with a list of neurological conditions.

30 Jan 2013

Geospatial technologies help track real-time movements of sex offenders

Convicted sex offenders continue to move freely within communities, including in restricted areas, despite laws designed to limit their movements. A new study, by Alan Murray from Arizona State University and colleagues, uses new tracking techniques to better understand the actual movements of sex offenders. This information can help develop effective strategies to promote public safety.

30 Jan 2013

Human Brain Project to link basic research with disease treatment

King's College London is part of an international consortium of scientists who have today been awarded a grant of over one billion euros, over ten years, to simulate 'everything we know about the human brain' in supercomputers.

30 Jan 2013

Sanofi introduces LeGoo gel to temporarily stop blood flow during cardiovascular surgery

Sanofi US announced the commercial launch of LeGoo, a biopolymer gel that allows surgeons to temporarily stop blood flow during surgery without the use of clamps, elastic loops or other conventional occlusion devices, which may increase risk of trauma to blood vessels.

30 Jan 2013

One-step, off-the-shelf tool can help evaluate genetic cause of mitochondrial diseases

More powerful gene-sequencing tools have increasingly been uncovering disease secrets in DNA within the cell nucleus. Now a research team is expanding those rapid next-generation sequencing tests to analyze a separate source of DNA—within the genes inside mitochondria, cellular power plants that, when abnormal, contribute to complex, multisystem diseases.

29 Jan 2013

ARGO launches ReWalk Rehabilitation 2.0 system

ARGO Medical Technologies has unveiled the newest generation of its ReWalk Rehabilitation exoskeleton that enables individuals with spinal cord injuries the ability to walk again.

29 Jan 2013

U-M researchers develop new method thet could enhance gene sequencing data

When researchers sequence the RNA of cancer cells, they can compare it to normal cells and see where there is more RNA. That can help lead them to the gene or protein that might be triggering the cancer.

29 Jan 2013

Colorectal cancer screening: an interview with Dr Donato F. Altomare

Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.

29 Jan 2013

Novel experiment illuminates importance of doctor-patient relationship

A patient's relationship with his or her doctor has long been considered an important component of healing. Now, in a novel investigation in which physicians underwent brain scans while they believed they were actually treating patients, researchers have provided the first scientific evidence indicating that doctors truly can feel their patients' pain - and can also experience their relief following treatment.

29 Jan 2013

New genetic test can help identify small aggressive lung tumors linked with poor survival

A novel genetic test can help identify small but aggressive lung tumors associated with poor survival, according to a study released today at the 49th Annual Meeting of The Society of Thoracic Surgeons held at the Los Angeles Convention Center.

29 Jan 2013

New tweet-screening method effectively tracks flu cases

Sifting through social media messages has become a popular way to track when and where flu cases occur, but a key hurdle hampers the process: how to identify flu-infection tweets. Some tweets are posted by people who have been sick with the virus, while others come from folks who are merely talking about the illness. If you are tracking actual flu cases, such conversations about the flu in general can skew the results.

29 Jan 2013

Gottlieb Memorial Hospital introduces Epic electronic medical record system

Gottlieb Memorial Hospital today introduced the Epic electronic medical record system for patients in the hospital. This new system will offer many benefits to patients and physicians.

29 Jan 2013

Blue light can selectively eradicate skin and soft tissue infections

Blue light can selectively eradicate Pseudomonas aeruginosa infections of the skin and soft tissues, while preserving the outermost layer of skin, according to a proof-of-principle study led by Michael R. Hamblin of the Massachusetts General Hospital, and the Harvard Medical School, Boston.

29 Jan 2013

Part of Human Brain Project focuses on Neurorobotics

Extensive knowledge about the human brain and its functioning already exists but is highly fragmented. The goal of the Human Brain Project is to pull together this knowledge and to reconstruct the brain, piece by piece, in supercomputer-based models and simulations. The models offer the prospect of a new understanding of the human brain and its diseases and of completely new computing and robotic technologies.

29 Jan 2013

Dual-hormone artificial pancreas shows promise against type 1 diabetes

IRCM researchers, led by endocrinologist Dr. R-mi Rabasa-Lhoret, were the first to conduct a trial comparing a dual-hormone artificial pancreas with conventional diabetes treatment using an insulin pump and showed improved glucose levels and lower risks of hypoglycemia.

29 Jan 2013